Swipe om te navigeren naar een ander artikel
Improving survival after esophagectomy is an important issue in treating patients with esophageal cancer (EC). In addition to standard hospitalization management, periodic assessment of quality-of-life (QOL) measures may be useful to detect disease progression from patients’ subjective reports. Therefore, this prospective longitudinal study was undertaken to identify prognostic factors for 3-year survival of EC patients after esophagectomy and to evaluate the impact of QOL measures on these prognostic factors.
Patients with EC (n = 67) who had a complete tumor resection and were alive 6 months after esophagectomy were followed in this study for 3 years. Data were collected on patients’ sociodemographics, cancer characteristics, adjuvant therapy, general QOL and EC-specific QOL (before esophagectomy and 6 months afterward), cancer recurrence, and death. Patients’ independent risk factors for 3-year survival were investigated by multivariate Cox regression analysis.
Of the 67 participants with EC, 26 had late mortality, with a median survival for the whole cohort of 38.2 months (95 % CI 31.97–44.35). Independent predictors of early death were early cancer recurrence (within 6 months after surgery), poor cognitive function (95 % CI 1.020–1.041), and worse dyspnea (95 % CI 1.007–1.034).
The most predictive factor for early death in EC patients after esophagectomy was cancer recurrence within 6 months after surgery. However, QOL measures could be a tool to provide clinical information from patients’ perspective suggesting cancer recurrence.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Zhang, Y. (2013). Epidemiology of esophageal cancer. World Journal of Gastroenterology, 19, 598–606. doi: 10.3748/wjg.v19.i34.5598.
Montgomery, E. A., Basman, F. T., Brennan, P., & Malekzadeh, R. (2014). Oesophageal cancer. In B. W. Stewart & C. P. Wild (Eds.), World cancer report 2014 (pp. 528–543). Geneva: World Health Organization.
Quinten, C., Coens, C., Mauer, M., Comte, S., Sprangers, M. A., Cleeland, C., et al. (2009). Baseline quality of life as a prognostic indicator of survival: A meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncology, 10, 865–871. doi: 10.1016/S1470-2045(09)70200-1. CrossRefPubMed
Van Heijl, M., Sprangers, M. A. G., de Boer, A. G. E., Lagarde, S. M., Reitsma, H. B., Busch, O. R. C., et al. (2010). Preoperative and early postoperative quality of life predict survival in potentially curable patient with esophageal cancer. Annals of Surgical Oncology, 17, 23–30. doi: 10.1245/s10434-009-0731-y. PubMedCentralCrossRefPubMed
Courrech Staal, E. F., van Sandick, J. W., van Tinteren, H., Cats, A., & Aaronson, N. K. (2010). Health-related quality of life in long-term esophageal cancer survivors after potentially curative treatment. Journal of Thoracic Cardiovascular Surgery, 140, 777–783. doi: 10.1016/j.jtcvs.2010.05.018. CrossRefPubMed
Healy, L. A., Ryan, A. M., Moore, J., Rowley, S., Ravi, N., Byrne, P. J., et al. (2008). Health-related quality of life assessment at presentation may predict complications and early relapse in patient with localized cancer of the esophagus. Diseases of the Esophagus, 21, 522–528. doi: 10.1111/j.1442-2050.2008.00814.x. CrossRefPubMed
American Joint Committee on Cancer. (2010). Cancer staging manual (7th ed., pp. 29–40). New York: Springer. CrossRef
Lerut, T., Moons, J., Coosemans, W., Van Raemdonck, D., De Leyn, P., Decaluwé, H., et al. (2009). Postoperative complications after transthoracic esophagectomy for cancer of the esophagus and gastroesophageal junction are correlated with early cancer recurrence. Annals of Surgery, 250, 798–807. doi: 10.1097/SLA.0b013e3181bdd5a8. CrossRefPubMed
Fayers, P., Aaronson, N. K., Bjordal, K., Groenvold, M., Curran, D., & Bottomley, A. (2001). The EORTC QLQ-C30 scoring manual (3rd ed.). Brussels: European Organization for Research and Treatment of Cancer.
Cox, D., & Oakes, D. (1984). Analysis of survival data. London: Chapman and Hall.
Campbell, M. J. (2001). Statistics at square two: Understanding modern statistical applications in medicine. London: BMJ Books.
Grotenhuis, B. A., Wijnhoven, B. P. L., Hötte, G. J., van der Stok, E. P., Tilanus, H. W., & Lanschot, J. J. B. (2010). Prognostic value of body mass index on short-term and long-term outcome after resection of esophageal cancer. World Journal of Surgery, 34, 2621–2627. doi: 10.1007/s00268-010-0697-8. PubMedCentralCrossRefPubMed
Luc, G., Durand, M., Chiche, L., & Collet, D. (2015). Major post-operative complications predict long-term survival after esophagectomy in patients with adenocarcinoma of the esophagus. World Journal of Surgery, 391, 216–222. CrossRef
Department of Health of Taiwan, Taipei, Taiwan. Health statistics. http://www.doh.gov.tw. Accessed May 18, 2015.
Chou, Q., Hong, J., & Chou, P. (1997). Prevalence of cigarettes smoking and betel nut chewing in Taiwan. Chinese Journal of Dental Research, 16, 28–36.
Speicher, P. J., Englum, B. R., Ganapathi, A. M., Mulvihill, M. S., Hartwig, M. G., Onaitis, M. W., et al. (2015). Adjuvant chemotherapy is associated with improved survival after esophagectomy without induction therapy for node-positive adenocarcinoma. Journal of Thoracic Oncology, 10, 181–188. CrossRefPubMed
Fang, F. M., Tsai, W. L., Chiu, H. C., Kuo, W. R., & Hsiung, C. Y. (2003). Quality of life as a survival predictor for esophageal squamous cell carcinoma treated with radiotherapy. International Journal of Radiation Oncology, Biology, & Physics, 58(5), 1394–1404. doi: 10.1016/j.ijrobp.2003.09.100. CrossRef
Almhanna, K., Shridhar, R., & Meredith, K. L. (2013). Neoadjuvant or adjuvant therapy for resectable esophageal cancer: Is there a standard of care? Cancer Control, 20, 89–96. PubMed
Ku, G. Y., & Ilson, D. H. (2007). Esophageal cancer: Adjuvant therapy. Cancer Journal, 13, 162–167. CrossRef
Carrieri-Kohlman, V. (2006). Non-pharmacologic approaches. In S. Booth & D. Dudgeon (Eds.), Dyspnoea in advanced disease: A guide to clinical management (p. 171). New York: Oxford University Press.
Wefel, J. S., Collins, R., & Kayl, A. E. (2008). Cognitive dysfunction related to chemotherapy and biological response modifiers. In C. A. Myers & J. R. Perry (Eds.), Cognition and cancer (p. 97). Cambridge: Cambridge University Press. CrossRef
- Quality-of-life measures as predictors of post-esophagectomy survival of patients with esophageal cancer
- Springer International Publishing